Mr. Fucidinum

Active material: Fusidic acid, Gidrokortizon
When ATH: D07CA01
CCF: Drug with antibacterial and anti-inflammatory for outdoor use
When CSF: 04.05
Manufacturer: LEO PHARMACEUTICAL PRODUCTS (Denmark)

Pharmaceutical form, composition and packaging

Cream for external application homogeneous, white.

Excipients: ʙutilgidroksianizol, cetyl alcohol, glycerol 85%, Liquid paraffin, potassium sorbate, polysorbate 60, white soft paraffin, 3M hydrochloric acid, Purified water.

15 g – aluminum tuba (1) – packs cardboard.

Pharmacological properties

Combined preparation for external use. It combines anti-inflammatory and antipruritic effects of hydrocortisone with the antibacterial action of fusidic acid. Highly active against Staphylococcus spp., especially Staphylococcus aureus and Staphylococcus epidermidis (including methicillin-resistant strains), Streptococcus spp., Neisseria spp., Clostridium spp. Nocardia asteroids, Enterococcus spp., Bacteroides spp.. Mycobacterium tuberculosis, Mycobacterium leprae и Corynebacterium minute. Antibakterilnaya active fusidic acid is not reduced in the presence of hydrocortisone.

Pharmacokinetics

The skin gets 2% of the applied amount of the drug. For external use systemic absorption is low.

Indications

Dermatitis in the presence of a bacterial infection or suspected it: atopic dermatitis, seborrheic dermatitis, a simple contact dermatitis, atopic dermatitis, eczema, chronic zoster, red discoid lupus.

Contraindications

Hypersensitivity to the drug. Lupus, cutaneous manifestations of syphilis, enable vetryanaya, viral and fungal infections of the skin, postvaktsionalnye skin reactions, open wounds, sores, Rosacea, acne vulgaris.

Use during pregnancy and breast-feeding

Experimental studies have shown, Fucidinum that T does not have embryotoxic and teratogenic. For external use Fucidinum T selection as fusidic acid, and hydrocortisone in breast milk is unlikely due to the low systemic adsorption. As the study in women during pregnancy and lactation has not been, during pregnancy the drug should not be used for a long time and in large quantities, breastfeeding – the drug should not be applied on the breast.

Dosing and Administration

Cream Fucidinum T applied to the affected area of ​​the skin with a thin layer 2 once a day. A course of treatment – 2 of the week.

Side effect

Side-effects when applied externally are rare, and are reversible. As with other glucocorticosteroids, in 1-2 % Patients may develop a hypersensitivity reaction (itch, burning, redness, pricking, xerosis, as well as irritation and rashes). Rarely can develop aknepodobnye changes. gipopigmentatsiya, folliculitis, striae, skin atrophy, hypertryhoz, contact type allergy.
In case of hypersensitivity reactions or side effects, therapy should be discontinued and seek medical advice!

Interaction with other drugs

Not identified.

Overdose

Exceeding the recommended dose, long-term use of local corticosteroids on extensive surfaces can lead to suppression of the hypothalamic-pituitary-adrenal system and the development of symptoms of Cushing. Treatment: It recommended a gradual withdrawal of the drug, simptomaticheskaya therapy, If necessary, a correction of electrolyte imbalance.

Cautions

Avoid prolonged use of the drug, particularly on the face and skin folds, as well as in children. Avoid contact with the eyes.

Product form

By 15 g in aluminum tube, sealed membrane of aluminum foil and sealed with plastic screw cap; by 1 tuba, along with instructions for use in a cardboard box.

Storage conditions

The temperature is not above 25 °, in the field, inaccessible to children.

Shelf life

3 year. Do not use beyond the expiration date.

Conditions of supply of pharmacies

Prescription.